GlobeNewswire
Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event
Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and business growth. Read more »- Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred StockNEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today that,… Read more »
- Pliant Therapeutics Provides Update on BEACON-IPFBexotegrast development in IPF discontinued Read more »
- RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health ScreeningCost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms Read more »
- INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesBoca Raton, Florida, June 27, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and… Read more »
- New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMACAMBRIDGE, Mass., June 27, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced new data that reinforce the clinical… Read more »
- Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private PlacementFREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) — Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging… Read more »
- Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder MarketVancouver, Canada, June 27, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a… Read more »
- Results of Annual General MeetingJune 27, 2023 Read more »
- CorMedix Inc. Announces Pricing of Public Offering of Common StockBERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and… Read more »
- Calidi Biotherapeutics Announces Shareholder Letter from CEOSAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering… Read more »
- Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical ScienceGLO targets the growing ”beauty-from-within” market with scientifically proven cellular defense and skin vitality benefits Read more »
- HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid TumorsTetra-functional T-cell engagers activate T cells and simultaneously reduce immunosuppression, with potent and antigen-specific anti-pancreatic cancer activities at dose levels… Read more »
- Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value RightEMERYVILLE, Calif. and SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) — XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and Turnstone… Read more »
- FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONSWEST PALM BEACH, FLORIDA, June 27, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today… Read more »
- BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million—Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to… Read more »
- Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung CancerBOSTON, June 27, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering the… Read more »
- Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesDEER PARK, Ill., June 27, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative… Read more »
- Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National SummitZUG, Switzerland, June 27, 2025 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2… Read more »
- Vivoryon Therapeutics N.V. to Present at Upcoming Investor ConferencesVivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences Read more »
- Kymera Therapeutics Announces Pricing of $250 Million Public OfferingWATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new… Read more »
- Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public OfferingSEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty… Read more »
- Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesSAN DIEGO, June 26, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary… Read more »
- Kane Biotech Announces Conversion of Demand Loan from Insider into an Unsecured Convertible Debenture and Annual General Meeting Voting ResultsNot for distribution to U.S. news wire services or dissemination in the United States Read more »
- Teva Releases Q2 2025 Aide MemoireTEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that… Read more »
- ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCPLEIDEN, Netherlands & CAMBRIDGE, Mass., June 26, 2025 (GLOBE NEWSWIRE) — ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated… Read more »
- Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its… Read more »
- Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its… Read more »
- Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem’s Hormone-Free, On-Demand Prescription Contraceptive GelWindtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Read more »
- Achieve Life Sciences Announces Proposed Underwritten Public OfferingSEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty… Read more »
- Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two DecadesOmnicom cross-agency collaboration to drive technology-led, innovative launch strategy Read more »
- Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking CessationSmoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone Read more »
- Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual ConferenceAclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference Read more »
- CorMedix Inc. Announces Proposed Public Offering of Common StockBERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and… Read more »
- INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30thCompany to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Read more »
- Indacloud Unveils Top Premium THCA Flower LineIntroducing Ice Cream Man, Skywalker OG Gold Edition, Red Velvet, Gold Cash Gold Edition, and Jedi Breath Introducing Ice Cream… Read more »
Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company
The new branding showcases the Company’s innovative vision for the future and mission to redefine the retina experience The new… Read more »- Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on… Read more »
Longeveron® Appoints Than Powell as Chief Business Officer
Than Powell appointed as Longeveron CBO to lead overall business strategy, Alzheimer’s program partnering and HLHS program international strategy. Read more »- Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public OfferingCUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage… Read more »
- Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z SquaredWEXFORD, Pa., June 26, 2025 (GLOBE NEWSWIRE) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen… Read more »
- Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin DiseasesNew episode spotlights the severe burden of Netherton Syndrome in infants and children, reinforcing the need for effective pediatric treatments… Read more »
- Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial OfficerIRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in… Read more »
- Cellectar Biosciences and U.S.-based Nusano Enter Into Multi-Isotope Supply AgreementPartnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Read more »
- aTyr Pharma to be Added to the Russell 2000® and Russell 3000® IndexesaTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes Read more »
- Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement FinancingSOLANA BEACH, Calif., June 26, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on… Read more »
- BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)Hybrid, decentralized trial of bezisterim in early Parkinson’s Disease prioritizes patient access and participation Hybrid, decentralized trial of bezisterim in… Read more »
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
Two iconic coastal-living brands team up for a limited-edition summer beer and capsule collection Two iconic coastal-living brands team up… Read more »- GRI Bio’s GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)The Independent Data Monitoring Committee (“IDMC”) has recommended to continue the study as planned as there are no safety concerns… Read more »
- Labviva Automates Chemical Supply Chain for the Life Sciences IndustryLabviva automates chemical supply chain for the Life Sciences industry. Read more »